title: Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr).
authors.affiliation: Merck, Whitehouse Station, NJ, USA.
authors.forename: C
authors.initials: C
authors.lastname: Nwankwo
authors.affiliation: Cleveland Clinic, Columbia, SC, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kattan
authors.affiliation: Agile 1, Torrance, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Luan
authors.affiliation: Merck, Whitehouse Station, NJ, USA.
authors.forename: J
authors.initials: J
authors.lastname: Wahl